Welaga Paul, Oduro Abraham, Debpuur Cornelius, Aaby Peter, Ravn Henrik, Andersen Andreas, Binka Fred, Hodgson Abraham
Navrongo Health Research Centre, P.O. Box 114, Navrongo, Ghana; OPEN, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
Navrongo Health Research Centre, P.O. Box 114, Navrongo, Ghana.
Vaccine. 2017 Apr 25;35(18):2496-2503. doi: 10.1016/j.vaccine.2017.03.004. Epub 2017 Mar 22.
Studies suggest that diphtheria-tetanus-pertussis (DTP) vaccine administered simultaneously with measles vaccine (MV) or DTP administered after MV are associated with higher child mortality than having MV-after-DTP3 as most recent vaccination. We tested this in Northern Ghana where the prevalence of such out-of-sequence vaccinations has declined.
Using annual cohort data of children aged 12-23months from 1996 to 2012 and Cox proportional hazards models, we assessed survival in relation to the most recent vaccination status within the next 12months and until five years of age. We assessed whether mortality in children aged 12-59months was higher when the most recent vaccine was non-live (DTP) rather than live (MV or OPV).
Out-of-sequence vaccinations with DTP-containing vaccines and MV declined from 86% in 1989 to 24% in 1996 and 0.7% in 2012. Between 1996 and 2012, 38 070 children had their vaccinations status assessed: the adjusted hazard ratio (HR) for out-of-sequence vaccinations (DTP>=MV) compared with the recommended sequence of MV-after-DTP3 was 1.42(1.06-1.90) during the first 12months after assessment of vaccination status and 1.29(1.03-1.60) with follow-up to five years of age; the HR was 2.58(1.14-5.84) before OPV or MV campaigns and 1.37(1.02-1.85) after the campaigns.
Out-of-sequence vaccinations with DTP and MV are associated with higher mortality than MV as most recent vaccination; the effect is unlikely to be due to confounding. Hence, the reduction in out-of-sequence vaccinations may have lowered child mortality. It is recommended not to give DTP with MV or DTP after MV.
研究表明,白喉-破伤风-百日咳(DTP)疫苗与麻疹疫苗(MV)同时接种,或在MV之后接种DTP,与儿童死亡率较高有关,而最近一次接种为MV在DTP3之后的情况相比,死亡率更高。我们在加纳北部对此进行了测试,在那里,这种不按顺序接种疫苗的情况有所减少。
利用1996年至2012年12至23个月大儿童的年度队列数据和Cox比例风险模型,我们评估了在接下来12个月内以及直至五岁时与最近一次疫苗接种状况相关的生存率。我们评估了在最近一次疫苗为非活疫苗(DTP)而非活疫苗(MV或OPV)时,12至59个月大儿童的死亡率是否更高。
含DTP疫苗和MV的不按顺序接种率从1989年的86%降至1996年的24%,2012年降至0.7%。1996年至2012年期间,对38070名儿童的疫苗接种状况进行了评估:与推荐的MV在DTP3之后的接种顺序相比,不按顺序接种(DTP>=MV)的调整后风险比(HR)在评估疫苗接种状况后的前12个月为1.42(1.06 - 1.90),随访至五岁时为1.29(1.03 - 1.60);在OPV或MV接种运动之前,HR为2.58(1.14 - 5.84),运动之后为1.37(1.02 - 1.85)。
与最近一次接种MV相比,DTP和MV的不按顺序接种与更高的死亡率相关;这种影响不太可能是由于混杂因素。因此,不按顺序接种的减少可能降低了儿童死亡率。建议不要将DTP与MV同时接种,也不要在MV之后接种DTP。